Buyang huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Cui, Han Jin ^a,b   Yang, A Li ^a,b   Zhou, Hua Jun ^b,c   Wang, Cong ^a,b   Luo, Jie Kun ^a,b   Lin, Yuan ^b   Zong, Yan Xia ^a,b   Tang, Tao ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Key Lab   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Angiogenesis; Buyang huanwu decoction; Intracerebral hemorrhage; Phosphorylation; PI3K Akt; Vascular endothelial growth factor receptor 2

Indexed keywords

BROXURIDINE; BUYANG HUANWU DECOCTION; CHINESE DRUG; COLLAGEN TYPE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SEMAXANIB; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; BUYANG HUANWU; HERBACEOUS AGENT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSESSMENT OF HUMANS; BRAIN BLOOD VESSEL; BRAIN FUNCTION; BRAIN HEMORRHAGE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; FOOT FAULT TEST; FUNCTION TEST; GLOBUS PALLIDUS; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; MOUSE; NEUROLOGICAL SEVERITY SCORE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; ASTRAGALUS (PLANT); BRAIN; CELL PROLIFERATION; CEREBRAL HEMORRHAGE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYTOTHERAPY; STROKE; VASCULARIZATION;

ANIMALS; ASTRAGALUS PLANT; BRAIN; CELL PROLIFERATION; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PHYTOTHERAPY; SIGNAL TRANSDUCTION; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84925858689     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0605-8     Document Type: Article

References (52)

1. Wang DZ, Talkad AV. Treatment of intracerebral hemorrhage: what should we do now? Curr Neurol Neurosci Rep. 2009;9(1):13-8.
2. Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6(11):593-601.
3. Andaluz N, Zuccarello M. Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database. J Neurosurg. 2009;110(3):403-10.
4. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol. 2010;92(4):463-77.
5. Wu H, Wu T, Li M, Wang J. Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury. Neurobiol Dis. 2012;45(1):388-94.
6. Chang CF, Cho S, Wang J. (-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Ann Clin Transl Neurol. 2014;1(4):258-71.
7. Chopp M, Zhang ZG, Jiang Q. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke. 2007;38(2 Suppl):827-31.
8. Kojima T, Hirota Y, Ema M, Takahashi S, Miyoshi I, Okano H, et al. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells. 2010;28(3):545-54.
9. Tiwari A, Jung JJ, Inamdar SM, Choudhury A. Membrane trafficking and endothelial-cell dynamics during angiogenesis. In: Lawrite C, editor. Hematology - Science and Practice. Rijeka: Tech; 2012. p. 253-80.
10. Katoh M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int J Mol Med. 2013;32(4):763-7.
11. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 2006;312(5):549-60.
12. Zan L, Zhang X, Xi Y, Wu H, Song Y, Teng G, et al. Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion. Neuroscience. 2014;262:118-28.
13. Tang T, Liu XJ, Zhang ZQ, Zhou HJ, Luo JK, Huang JF, et al. Cerebral angiogenesis after collagenase-induced intracerebral hemorrhage in rats. Brain Res. 2007;1175:134-42.
14. Roskoski Jr R. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun. 2008;375(3):287-91.
15. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-76.
16. Smith JK, Mamoon NM, Duhe RJ. Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy. Oncol Res. 2004;14(4-5):175-225.
17. Zhong XS, Zheng JZ, Reed E, Jiang BH. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway. Biochem Biophys Res Commun. 2004;324(2):471-80.
18. Kieran MW, Supko JG, Wallace D, Fruscio R, Poussaint TY, Phillips P, et al. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer. 2009;52(2):169-76.
19. Liu H, Zhang GP, Song SJ, Ding MP, Zhou JF, Bie XD, et al. Clinical study on Zhuyu Tongfu serial recipe combined with acupuncture and massotherapy in treating hypertensive cerebral hemorrhage. Chin J Integr Med. 2005;11(3):167-72.
20. Wei RL, Teng HJ, Yin B, Xu Y, Du Y, He FP, et al. A systematic review and meta-analysis of buyang huanwu decoction in animal model of focal cerebral ischemia. Evid Based Complement Alternat Med. 2013;2013:138484.
21. Zhao LD, Wang JH, Jin GR, Zhao Y, Zhang HJ. Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats-time window and mechanism. J Ethnopharmacol. 2012;140(2):339-44.
22. Cai G, Liu B, Liu W, Tan X, Rong J, Chen X, et al. Buyang Huanwu Decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains. J Ethnopharmacol. 2007;113(2):292-9.
23. Hao CZ, Wu F, Shen J, Lu L, Fu DL, Liao WJ, et al. Clinical efficacy and safety of buyang huanwu decoction for acute ischemic stroke: a systematic review and meta-analysis of 19 randomized controlled trials. Evid Based Complement Alternat Med. 2012;2012:630124.
24. Zhang ZQ, Tang T, Luo JK, Huang JF, Yang QD, Li XQ, et al. Effect of qi-tonifying and stasis-eliminating therapy on expression of vascular endothelial growth factor and its receptors Flt-1, Flk-1 in the brain of intracerebral hemorrhagic rats. Chin J Integr Med. 2007;13(4):285-90.
25. Adjei AA. Novel small-molecule inhibitors of the vascular endothelial growth factor receptor. Clin Lung Cancer. 2007;8 Suppl 2:S74-8.
26. Narantuya D, Nagai A, Sheikh AM, Masuda J, Kobayashi S, Yamaguchi S, et al. Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS ONE. 2010;5(7):e11746.
27. Krafft PR, McBride DW, Lekic T, Rolland WB, Mansell CE, Ma Q, et al. Correlation between subacute sensorimotor deficits and brain edema in two mouse models of intracerebral hemorrhage. Behav Brain Res. 2014;264:151-60.
28. Cecatto RB, Maximino JR, Chadi G. Motor recovery and cortical plasticity after functional electrical stimulation in a rat model of focal stroke. Am J Phys Med Rehabil. 2014;93(9):791-800.
29. Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, Ramchandran R, et al. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin alphavbeta(3). Blood. 2011;118(7):2015-26.
30. Shimotake J, Derugin N, Wendland M, Vexler ZS, Ferriero DM. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke. 2010;41(2):343-9.
31. Skold MK, Risling M, Holmin S. Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. Eur J Neurosci. 2006;23(1):21-34.
32. Li WL, Fraser JL, Yu SP, Zhu J, Jiang YJ, Wei L. The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice. Exp Brain Res. 2011;214(4):503-13.
33. Dellinger MT, Brekken RA. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium. PLoS ONE. 2011;6(12):e28947.
34. Jiang BH, Zheng JZ, Aoki M, Vogt PK. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A. 2000;97(4):1749-53.
35. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 2007;404(1):15-21.
36. O'Farrell AM, Yuen HA, Smolich B, Hannah AL, Louie SG, Hong W, et al. Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia. Leuk Res. 2004;28(7):679-89.
37. Fournier NM, Lee B, Banasr M, Elsayed M, Duman RS. Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling. Neuropharmacology. 2012;63(4):642-52.
38. Zhang L, Liu Q, Lu L, Zhao X, Gao X, Wang Y. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1alpha accumulation via phosphatidylinositol 3-kinase/Akt pathway. J Pharmacol Exp Ther. 2011;338(2):485-91.
39. Urschel K, Garlichs CD, Daniel WG, Cicha I. VEGFR2 signalling contributes to increased endothelial susceptibility to TNF-alpha under chronic non-uniform shear stress. Atherosclerosis. 2011;219(2):499-509.
40. Urbich C, Stein M, Reisinger K, Kaufmann R, Dimmeler S, Gille J. Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding. FEBS Lett. 2003;535(1-3):87-93.
41. van der Meer AD, Li Y, Duits MH, Poot AA, Feijen J, Vermes I. Shear stress induces a transient and VEGFR-2-dependent decrease in the motion of injected particles in endothelial cells. Biorheology. 2010;47(3-4):179-92.
42. Sho E, Komatsu M, Sho M, Nanjo H, Singh TM, Xu C, et al. High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor. Exp Mol Pathol. 2003;75(1):1-11.
43. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5(1):53-63.
44. Wu X, Li Y, Liu H, Yin Y, Zhao S, Guo Y. Microvessel changes in the gerbil hippocampus after cerebral ischemia and reperfusion by Buyang Huanwu decoction pretreatment. Neural Regen Res. 2011;6(9):656-60.
45. Reshef A, Shirvan A, Shohami E, Grimberg H, Levin G, Cohen A, et al. Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J Neurotrauma. 2008;25(6):569-80.
46. Tsenter J, Beni-Adani L, Assaf Y, Alexandrovich AG, Trembovler V, Shohami E. Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J Neurotrauma. 2008;25(4):324-33.
47. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods. 2002;117(2):207-14.
48. Imbe H, Okamoto K, Donishi T, Senba E, Kimura A. Involvement of descending facilitation from the rostral ventromedial medulla in the enhancement of formalin-evoked nocifensive behavior following repeated forced swim stress. Brain Res. 2010;1329:103-12.
49. Kleim JA, Boychuk JA, Adkins DL. Rat models of upper extremity impairment in stroke. ILAR J. 2007;48(4):374-84.
50. Del Bigio MR, Yan HJ, Campbell TM, Peeling J. Effect of fucoidan treatment on collagenase-induced intracerebral hemorrhage in rats. Neurol Res. 1999;21(4):415-9.
51. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009;8(5):491-500.
52. Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE. 2007;2(1):e156.